Skip to content
Prices checked against public provider pages Current, monitored and future routes kept separate Prescription medicines require clinical assessment
Medicine comparison

Updated 12 July 2026

Orlistat vs GLP-1 tablets UK: what should people compare?

Orlistat and the Wegovy pill are both discussed in weight-loss searches, but they are not interchangeable medicines. They work differently, follow different prescribing routes and have different side-effect and suitability questions.

Short answer: Orlistat is an established non-GLP-1 medicine that reduces dietary fat absorption. The Wegovy pill is oral semaglutide for weight management and is now listed by UK private providers. The better route depends on clinical eligibility, treatment preferences, side-effect tolerance and the support you need, not simply the lowest headline price.

Compare current tablet providers

How the medicines work

Orlistat reduces the amount of dietary fat absorbed from meals. Its digestive effects are closely linked to dietary fat, which is why food choices and practical advice are part of the decision.

The Wegovy pill contains oral semaglutide and works through GLP-1 pathways involved in appetite and fullness. It is a prescription route requiring clinical assessment and product-specific instructions.

Rybelsus is also oral semaglutide, but its established UK role is type 2 diabetes. It should not be presented as a general weight-loss alternative simply because it is a tablet.

What is available in the UK?

Route Current UK context What to check
Orlistat Established option, including prescription and pharmacy routes depending on the product. Exact product, eligibility, diet-related effects, interactions and source of supply.
Wegovy pill Live private-provider listings are now visible, although strengths and stock vary. Provider assessment, exact strength, public price, stock wording and review date.
Rybelsus Oral semaglutide for type 2 diabetes. Do not confuse its diabetes indication with a weight-loss route.
Orforglipron / Foundayo Future-watch for UK readers, not a live UK price-comparison row. UK licensing, supply and prescribing evidence rather than overseas headlines.

Cost and access are different questions

Orlistat is usually the lower-cost route, particularly when comparing pharmacy or generic options. The Wegovy pill is newer and private-provider prices vary by strength, programme and provider. A first-month offer, subscription price or bundle should not be treated as the same thing as a standard ongoing price.

For current dose-by-dose Wegovy-pill rows, use the provider comparison. For Orlistat, use the Orlistat guide and its provider listings. Open the individual provider page before relying on a figure because consultation, delivery, pack and offer terms can change.

Side-effect patterns are not interchangeable

Orlistat can cause digestive effects such as oily stools, urgency and increased bowel movements, particularly after meals high in fat. Oral semaglutide can cause nausea, vomiting, diarrhoea, constipation and other gastrointestinal symptoms, especially around treatment changes. Those are broad patterns, not a personal prediction.

Seek medical advice if symptoms are persistent or difficult to manage. Repeated vomiting or diarrhoea can cause dehydration. Severe or persistent abdominal pain, serious allergy symptoms or a symptom that feels urgent needs prompt medical help. Follow the product leaflet and the prescriber’s instructions rather than changing a dose yourself.

Which route may be worth discussing?

Orlistat may be worth discussingIf you want an established non-GLP-1 option and understand the meal-related digestive trade-off.
Wegovy pill may be worth discussingIf a clinician considers an oral semaglutide route suitable and you can follow its daily instructions and monitoring plan.
Neither is automatically rightMedical history, current medicines, pregnancy plans, eating pattern and treatment goals can change the answer.

Questions to ask a provider

  1. Which exact medicine and strength is being offered?
  2. What is the standard ongoing price after any introductory offer?
  3. What consultation and follow-up support are included?
  4. What symptoms should prompt a call to the provider or pharmacist?
  5. Which medicines, conditions or pregnancy plans should be disclosed?

What this comparison cannot tell you

A price table cannot decide suitability, predict weight loss or replace a consultation. It also cannot make an unlicensed or future medicine into a current UK option. A responsible comparison keeps medicine identity, indication, access status and price basis visible together.

Frequently asked questions

Is Orlistat a GLP-1 medicine?

No. Orlistat reduces fat absorption in the gut and belongs to a different medicine class.

Which is cheaper in the UK?

Orlistat is generally lower cost, but compare like-for-like product, pack, consultation and delivery terms rather than only the first headline number.

Is Rybelsus the same as the Wegovy pill?

Both contain oral semaglutide, but they have different licensed uses and product instructions. Rybelsus should not be treated as a general weight-loss substitute.

Is Orforglipron part of the live comparison?

No. It remains a future-watch medicine for UK readers until UK-specific licensing, supply and prescribing information are confirmed.

Official sources